← Evidence map

ReviewNephron2016

Targeting Glycosphingolipid Metabolism to Treat Kidney Disease.

James A ShaymanPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

17 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 26954668